COLESTIPOL Drug Patent Profile
Which patents cover Colestipol, and when can generic versions of Colestipol launch?
Colestipol is a drug marketed by Impax Labs, Ani Pharms, Edenbridge Pharms, Macleods Pharms, Riconpharma Llc, and Zydus Pharms. and is included in seven NDAs.
The generic ingredient in COLESTIPOL is colestipol hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Colestipol
A generic version of COLESTIPOL was approved as colestipol hydrochloride by IMPAX LABS on October 24th, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for COLESTIPOL?
- What are the global sales for COLESTIPOL?
- What is Average Wholesale Price for COLESTIPOL?
Summary for COLESTIPOL
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 7 |
| Drug Prices: | Drug price information for COLESTIPOL |
| DailyMed Link: | COLESTIPOL at DailyMed |
US Patents and Regulatory Information for COLESTIPOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | COLESTIPOL HYDROCHLORIDE | colestipol hydrochloride | GRANULE;ORAL | 077277-001 | May 2, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Riconpharma Llc | COLESTIPOL HYDROCHLORIDE | colestipol hydrochloride | TABLET;ORAL | 217462-001 | Dec 3, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Edenbridge Pharms | COLESTIPOL HYDROCHLORIDE | colestipol hydrochloride | TABLET;ORAL | 217667-001 | Aug 16, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
